Trials / Completed
CompletedNCT00291746
Validation of RDQ Questionnaire
A Single-Blind Single Arm Study to Validate the Reflux Disease Questionnaire (RDQ) for the Diagnosis of Reflux Disease in Primary Care in Patients Treated With Esomeprazole 40 mg o.d.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 350 (planned)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to determine the accuracy of the Reflux Disease Questionnaire (RDQ) as a diagnostic test for gastroesophageal reflux disease. Symptom evaluation by the RDQ will be compared with other established approaches to the diagnosis of gastroesophageal reflux disease (GERD) in a primary care patient population with symptoms thought to be of upper gastrointestinal (GI) tract origin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Esomeprazole | |
| PROCEDURE | Bravo technique |
Timeline
- Start date
- 2005-09-01
- Completion
- 2006-11-01
- First posted
- 2006-02-15
- Last updated
- 2009-03-12
Locations
30 sites across 6 countries: Canada, Denmark, Germany, Norway, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT00291746. Inclusion in this directory is not an endorsement.